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This study was performed to examine themaintenance of blood vessels in vitro in cortical organotypic slice cultures ofmice with special
emphasis on basic fibroblast growth factor (FGF-2), which is known to promote angiogenesis and to preserve the integrity of the
blood–brain barrier. Slices of neonatal day 3 or 4 mouse brain were maintained for 3, 7, or 10 d in vitro (DIV) under standard culture
conditions or in the presence of FGF-2. Immunohistochemistry for factor VIII-related antigen or laminin revealed a relative low number
of blood vessels under standard conditions. In contrast, moderate FGF-2 concentrations increased the number of vessels: with 0.5 ng/ml
FGF-2 it was 1.4-fold higher after DIV 3 or 1.5-fold after DIV 7 compared with controls; with 5 ng/ml it was almost doubled in both cases.
With an excess of 50 ng/ml, FGF-2 vessels were reduced after DIV 3 or similar to controls after DIV 7. FGF receptor 1 was preferentially
found on endothelial cells; its immunolabeling was reduced in the presence of the ligand. Cell death detected by an ethidium bromide
analog or the apoptosis marker caspase-3 was barely detectable during the 10 d culture period. Immunolabeling of the tight junction
proteins ZO-1 (zonula occludens protein 1), occludin, claudin-5, and claudin-3 revealed evidence for structural integrity of the blood–
brain barrier in the presence of moderate FGF-2 concentrations. In conclusion, FGF-2maintains blood vessels in vitro and preserves the
compositionof the tight junction.Hence,wepropose FGF-2-treated organotypic cortical slices as anew tool formechanistic studies of the
blood–brain barrier.
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Introduction
The blood–brain barrier (BBB) is an endothelial barrier sealed by
an extensive network of interendothelial tight junctions (TJs)
(Kniesel and Wolburg, 2000). Diseases such as stroke and epi-
lepsy induce disturbances of the BBB with deleterious influences
on neuronal function. In vitromodels of the BBB employ cultures
of dissociated endothelial cells or cocultures with astrocytes.
However, the unique BBB phenotype of brain endothelial cells is
the result of the continuous influence from the surrounding ner-
vous tissue, including pericytes, perivascular microglia, astro-
cytes, and the basal lamina, although the details of this interaction
are still unclear (Bauer and Bauer, 2000; Abbott, 2002; Haseloff et
al., 2005).
The establishment of an in vitro BBB model of cortical orga-
notypic slice cultures (COSCs) that takes the structural connec-
tivity of the cerebral tissue elements into account offers the
unique possibility to study single tissue elements under different
experimental conditions in the complex environment of the
brain. Compared with conventional BBB models, the blood ves-
sels remain in situ, in a maintained structure that allows cell–cell
interactions between natural in vivo partners. We therefore char-
acterized cerebral microvessels and features of the BBB in the
presence of basic fibroblast growth factor (FGF-2) in COSCs of
newborn mice.
FGF-2 is produced primarily by astrocytes in close proximity
to endothelial cells of the BBB (Sobue et al., 1999) andmimics the
signaling actions of astrocytes to the BBB (Garberg, 1998, Klint et
al., 1999). It binds to FGF receptor 1 (FGFR1) on endothelial
cells, exhibits a wide range of angiotrophic effects, and activates
signaling pathways involved in regulating endothelial cell sur-
vival (Garberg, 1998; Sobue et al., 1999). FGF-2 has also been
found to decrease the permeability of the BBB in vitro (ElHafny et
al., 1996), which is consistent with the finding that mutant mice
lacking FGF-2 showdecreased levels of the tight junctionproteins
occludin and ZO-1 and defects in BBB function (Reuss et al.,
2003). Thus, we assumed that FGF-2might also be a suitable tool
to preserve BBB integrity of blood vessels in COSCs of mice and
studied its influence on their persistence and structural integrity.
However, blood vessels might perish as a result of trauma
caused by explantation and dissection of the slice cultures. Fur-
thermore, the absence of intraluminal blood perfusion might
cause regressive changes affecting the BBB in the course of time.
In fact, so far nothing is known about the specific fate of tight
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junction proteins of the BBB in explanted
brain tissue, in particular of claudin-5 and
claudin-3, which have been shown to be
involved in the establishment andmainte-
nance of the BBB in cerebral microvessels
of mice (Nitta et al., 2003, Wolburg at al.,
2003).
Here, we show for the first time that
moderate concentrations of FGF-2 pro-
mote maintenance of vascular structures
in COSCs of mouse brain and enhance
their number in a concentration-
dependent manner. It also benefits the
maintenance of interendothelial TJs and,
thus, BBB function, as indicated by the
presence of the tight junction proteins
claudin-5, claudin-3, occludin, and ZO-1.
Materials andMethods
Culture protocol. COSCs were prepared and
cultivated according to Stoppini et al. (1991)
and Radojevic and Kapfhammer (2004) with
slight modifications. Postnatal day 3 (P3) to P4
wild-type mouse pups were rapidly decapi-
tated. After removing the brains, the cortex was
roughly dissected together with parts of the un-
derlying striatum or diencephalon, and 350-
m-thick coronal slices were cut on a tissue
chopper. Slices were separated, placed on
Millicell-CM 0.4 m culture plates (six slices
per membrane; Millipore, Zug, Switzerland) in
six-well dishes and were maintained in culture
medium, at 37°C in a humidified CO2-enriched
atmosphere for a minimum of 3 d to allow tissue
recovery fromexplantation trauma.Themedium
consisted of HEPES-buffered minimal essential
medium (50%), HBSS (25%), and heat-
inactivated horse serum (25%) complemented
with glutamax (2 mM; Invitrogen, Eugene, OR)
and adjusted to pH 7.3.
FGF-2 (Peprotech, London, UK) was added
to the medium (0.5, 5, or 50 ng/ml, respec-
tively) and medium was changed every other
day. Control sliceswere not treatedwith FGF-2.
No antibiotics or antimitotics were used.
Preparation for immunohistochemistry. The
cellular differentiation of the slices and the for-
mation of blood vessels was analyzed by immu-
nofluorescence. Cultures were fixed for 2 h at
room temperature (RT) with 4% PFA in PBS,
rinsed three times with PBS, and incubated in
blocking solution (BS) containing PBS, 0.5%
Triton X-100, and 3% normal goat serum for
20 min at RT.
Primary antibodies were diluted in BS as fol-
lows: rabbit polyclonal anti-factor-VIII-related
antigen (FVIII-rAg; 1:250; Dako, High Wy-
combe, UK), mouse monoclonal anti FGFR1
(1:250–1:1000; Millipore) rabbit polyclonal
anti-laminin (1:75; Sigma, St. Louis, MO), rabbit polyclonal anti-
caspase-3 (1:250; R & D Systems, Minneapolis, MN), rabbit polyclonal
anti-occludin (1:100; Zymed, San Francisco, CA), rabbit polyclonal anti-
ZO1 (1:100; Zymed), mouse monoclonal anti-claudin-5 (1:50; Zymed),
mouse monoclonal anti-claudin-3 (1:100; Zymed), rabbit polyclonal
anti-GFAP (1:250), and mouse monoclonal anti-NeuN (1:250) against
the DNA-binding neuron-specific protein.
Cultures were incubated overnight at 4°C, rinsed with PBS at RT, and
incubated with Alexa Fluorochromes (Invitrogen) in BS for 2 h at RT.
Unspecific staining was studied by omitting the primary antibody. The
slices were mounted on glass slides with Vectashield mounting medium
(Vector Laboratories, Burlingame, CA) and viewed on a Zeiss
(Oberkochen, Germany) Axiophot-microscope equipped with an Axio-
camHR camera. Recorded images were adjusted for brightness and con-
trast with Photoshop (Adobe, San Jose, CA).
Confocal microscopy. Fluorescently immunolabeled slices were ana-
Figure1. Demonstration ofmicrovessels in neonatal cortical slices under FGF-2 treatments.A–C, Immunofluorescence images
labeled for FVIII-rAg revealed the presence ofmicrovessels in COSCs after incubationwith 5 ng/ml FGF-2 at DIV 3 (A), DIV 7 (B), and
DIV 10 (C). Vessels appear as intact and frequently branching structures with continuous lines (arrows) and intersections (circles).
D, Immunostaining for laminin also shows the complexity of the vascular network at DIV 10 after 5 ng/ml FGF-2. E, F, Control
explants without FGF-2 displayed less labeling for FVIII-rAg at DIV 3 (E) and DIV 7 (F ). Note discontinuous arrows marking few
discontinuous vascular structures.G, In presence of 50 ng/ml FGF-2 at DIV 7 virtually no immunolabelingwas observed.H, Control
slice omitting the first antibody. Scale bars, 100m.
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lyzed using confocal laser scanning microscopy (LSM) (TCS4D; Leica
Microsystems, Mannheim, Germany) equipped with an Ar, Kr-laser and
an acousto-optical device (acousto-optic tunable filter module). Operat-
ing in the simultaneous acquisition mode, images were recorded with an
apochromatic 100 numerical aperture (NA) 1.4 objective lens. After
processing with a median filter to suppress background, image stacks
were analyzed with the colocalization module of the Imaris software
package (Bitplane, Zurich, Switzerland). Images were acquired and re-
constructed using the Leica LSM software, cropped, adjusted, and opti-
mized in Photoshop 9.0 (Adobe).
Determination of cell death. Cell death was visualized by application of
the fluorescent probe Ethidium-homodimer1 (EthD-1, Life/Dead Kit;
Invitrogen). EthD-1 enters cells with damaged membranes and under-
goes a 40-fold enhancement of fluorescence after binding to nucleic ac-
ids, thereby producing a bright red fluorescence in nuclei of dead cells.
EthD-1 is excluded by the intact plasmamembrane of live cells. Apopto-
sis was visualized by caspase-3 labeling.
Quantification and statistics. The vascular network was quantified ac-
cording to Moser et al. (2003) with some modifications. The number of
vascular crossings was counted in a 6 6 grid (100 100 m per single
square; total field, 0.25 mm2). Recorded images of the cortical slices
(10  0.63 magnification), were overlaid with three grids per slice in
Photoshop and three slices per animal were analyzed. Values in Figure 2
(in brackets) represent the mean of individual slices. Statistical analysis
was performed by one-way ANOVA with a subsequent Bonferroni cor-
rection as post hoc test ( p 0.05 was defined as significant).
Results
Vessels persist at moderate concentrations of FGF-2
Cerebral microvessels in slices from P3 and P4 mice responded
strongly to specific concentrations of FGF-2 exposure as shown
by labeling for FVIII-rAg, which is one of the best markers for the
identification of endothelial cells and consequently of vascular
structures (Fig. 1).
Control slices without FGF-2 contained a relative low number
of FVIII-rAg-positive vessels at 3 d in vitro (DIV), which further
decreased at DIV 7. With moderate FGF-2 concentrations, the
number of vessels increased compared with controls: in the pres-
ence of 0.5 ng/ml FGF-2, it increased 1.4-fold at DIV 3 and 1.5-
fold after DIV 7; with 5 ng/ml FGF-2 it increased 1.8-fold or
twofold, respectively (Fig. 2). In contrast, with 50 ng/ml FGF-2,
the number of vessels decreased 1.7-fold at DIV 3 compared with
controls and remained at control level at DIV 7. Generally, except
for the 50 ng/ml collective, vessels disappear with culture time,
50% fewer vessels were found at DIV 7 compared with DIV 3.
Qualitatively, the vascular network was more complex in the
presence of 0.5 or 5 ng/ml FGF-2. Vessels appeared as continuous
structures after DIV 3 (Fig. 1A) andDIV 7 (Fig. 1B). Even at DIV
10, a complex vascular network was observed (Fig. 1C), which
was also evident by labeling for the extracellular matrix protein
laminin (Fig. 1D). In contrast, without FGF-2, few fragmentary
vessels were detected after DIV 3 (Fig. 1E) and DIV 7 (Fig. 1F).
Virtually no FVIII-rAg-labeled vessels were found in slices
treated with an excess of 50 ng/ml FGF-2 at DIV 7 (Fig. 1G).
FGFR1 is localized on cerebral vessels
To show the specificity of the FGF-2 effect on the blood vessels,
staining with FGFR1 antibody at DIV 7 was performed together
with the vascular marker laminin. Confocal microscopic analysis
showed that the laminin staining outlined the blood vessels and
that the FGFR1 immunoreactivity was present in localized areas
of the blood vessel wall (Fig. 3A–C). Colocalization analysis (Fig.
3A–C, insets) revealed a strong colocalization of the FGFR1 im-
munoreactivity with the laminin staining. This was the case both
for tiny capillaries (Fig. 3A) as for larger vessels (Fig. 3B,C). The
immunohistochemical detection of the FGFR1 was more pro-
nounced in the absence of FGF-2 treatment (Fig. 3A,B) com-
pared with the FGF-2-treated slice cultures (Fig. 3C). This re-
duced immunoreactivity might be attributable to the occupation
Figure 2. Quantification of vascular segments. Counting of microvessels revealed a relative
lownumberof vessels in controls,which increased innumber in a concentrationdependentway
up to 5 ng/ml FGF-2, independent from the duration of culture (e.g.,1.5-fold at 0.5 ng/ml
and 2-fold at 5 ng/ml). Excessive amounts of 50 ng/ml FGF-2were ineffective in preventing loss
of vessels compared with controls. The absolute number of microvessels was halved at DIV 7
compared with DIV 3. Significances are given versus controls (*p 0.05; ***p 0.01). Error
bars indicate SEM.
Figure3. Localization of FGFR1.A–D, Colocalization of FGFR1 and the vascularmarker lami-
nin (A–C) or the astrocyte marker GFAP (D) is demonstrated by double immunofluorescence
laser confocalmicroscopy. FGFR1 immunoreactivity is shown in red and laminin or GFAP immu-
noreactivity are shown in green in these images. Yellow indicates colocalization. Degree of
colocalization is also indicated in thediagrams shownas insets inA–D. Laminin staining reveals
the outline of typical capillaries (A) and larger microvessels (B, C) at DIV 7. FGFR1 staining
localizes to subregions of the vessels; only little andweak expression of FGFR1 immunoreactiv-
ity is found outside of the vasculature. Note themore extensive expression of FGFR1 in controls
(A, B) compared with FGF-2-treated slices (C). Virtually no colocalization of FGFR1 was seen
with astrocytes stained for GFAP (D). All imageswere recordedwith an apochromatic 100NA
1.4 objective lens.
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of FGFR1 by its ligand in the FGF-2-treated slices. We also ana-
lyzed whether FGFR1 immunoreactivity showed a colocalization
with the astrocytic marker GFAP. Virtually no colocalization was
seen in astrocytes stained for GFAP (Fig. 3D), indicating that the
receptor is expressed mainly by endothelial cells and/or other
cells of the vascular wall. Together these
findings suggest that the endothelial cells
of the blood vessel are likely to be the pri-
mary target of the FGF-2 treatment.
Vessels persist in a healthy environment
Because CNS tissue is sensitive to minor
environmental variations, it was impor-
tant to verify whether, in our culture con-
ditions, cell death did occur in the slices,
potentially compromising the integrity of
the vascular system.
The organotypic cytoarchitecture of
the cortex remained well preserved with
moderate concentrations of FGF-2 (Fig.
4). Neurons were identified by their im-
munoreactivity against the DNA-binding,
neuron-specific protein NeuN, which is
present inmost neuronal cell types. Label-
ing revealed many NeuN-positive cells in
the presence of FGF-2 at DIV 7, indicating
neuronal differentiation (Fig. 4A). Astro-
cytes were identified by their immunore-
activity against GFAP, an intermediate fil-
ament expressed exclusively in the brain.
GFAP labeling at DIV 7 showed evenly
distributed, star-shaped astrocytes with
multiple branching processes throughout
the cortex in untreated controls (Fig.
5B–D) and in the presence of FGF-2 (Fig.
5F–K). The tips of their vascular processes
were plastered along the vessels as shown
by double staining of GFAP (green) and
FVIII-rAg (red) in the untreated controls
(Fig. 5D) as well as in the presence of
FGF-2 (Fig. 5H–K). However, without
FGF-2, most blood vessels have already
disappeared at DIV 7 (Fig. 1F) and the few
remaining vascular structures (as shown
exemplarily in Fig. 5A) appear extremely
dilated.
At moderate concentrations of FGF-2,
cell death either of the vascular endothelial
cells or of the neighboring cells was barely
observed after DIV 7 (Fig. 4B). Cell death
was nearly absent in the cortex as visual-
ized by double staining for FVIII-rAg and
EthD-1 (Fig. 4E,F), as well as by double
staining for laminin and the apoptosis-
marker caspase-3 (Fig. 4L–O). Just a few
dead nuclei were visible (Fig. 4E,F, ar-
rows), but a considerable amount of intact
microvessels could be shown with FVIII-
rAg (Fig. 4C,D). At DIV 10 (Fig. 4G–O),
some slices showed signs of beginning de-
generation of the nervous tissue in their
center (Fig. 4 I,K,M), which was related to
the subcortical nervous tissue. However,
even at DIV 10, cell death was absent in
cortical microvessles (Fig. 4O).
Cell death was also barely detected in controls and in slices
treated with 50 ng/ml FGF-2 (data not shown). This might be
attributable to the fact that, under these conditions, most vessels
Figure 4. Survival of the slice culture.A,B, The organotypic cytoarchitecture of the cortex remainedwell preserved (A) and the
overall survival of the tissue was superior in the presence of 5 ng/ml FGF-2 (B). A, Inset, NeuN labeling of neurons revealed well
differentiated cells. B, Cell death as shown by EthD-1 staining was barely observed at DIV 7. C–K, Images of cortical slices labeled
for FVIII-rAg antibody (green) and EthD-1 (red) at DIV 7 (C–F ) and DIV 10 (G–K ). C, Inset,D–F, Cell death of vascular endothelial
cells was not observed in the presence of 5 ng/ml FGF-2 at DIV 7. Just a few dead cells occurred in the adjacent nervous tissue (E,
arrows, F, overlay).G, Inset,H–K, At DIV 10, degeneration of the nervous tissuewas apparent, but it occurredmainly in the center
of the slices (I, arrows, K, overlay), indicating the degeneration of neurons and astrocytes rather than endothelial cells of cortical
vessels. L–O, Apoptotic cell death as shown by caspase-3 staining (red) was nearly absent in the cortical regions of the cultures
including cortical blood vessels (laminin staining, green) in the presence of 5 ng/ml FGF-2 at DIV 10. Apoptotic degeneration of the
nervous tissuewas observed sometimes in the center of the slices in the subcortical regions. c, Cortical; s.c., subcortical. Scale bars,
100m.
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and, thus, degenerated vascular fragments, already had
disappeared.
Generally, vessels appear to survive better in explants of
younger (P3–P4) pups, compared with older (P5–P7) pups (data
not shown), probably because of the better survival of the ner-
vous tissue from younger pups. Thus, for the visualization of the
tight junction proteins, P4 animals were used.
Vessels maintain their tight junctions
The microvessels in FGF-2-treated slices kept their in vivo struc-
tural integrity as shown by the presence of the tight junction
proteins claudin-5 (Fig. 6B–D) (and overlay with laminin F),
claudin-3 (Fig. 6G–K), ZO-1 (Fig. 6L), and occludin (Fig. 6M).
Their distribution coincided well with the expected localization
of tight junction-like structures: continuous, large bands of tight
junction proteins were present in the walls of the vascular struc-
tures; Figure 6D–F demonstrates exemplarily the localization of
claudin-5 and laminin along the vessel walls. Tight junction pro-
teins also regularly delineate adjacent endothelial cells (Fig. 6 J,K,
arrowheads) as well as the intersections of microvessels (G,H,
arrows). Thus, in the proposed COSCmodel, putative regressive
changes do not affect tight junction structures in the proposed
time-window of culture.
Discussion
The BBB is challenged in a variety of CNS infectious and neuro-
degenerative diseases, butmost of the studies concerning the BBB
are performed in vivo in animalmodels, which are not adapted to
the study of the underlying mechanistic events. Thus, one of the
major issues in BBB research is the development of representative
in vitromodels.
Although most in vitromodels rely on cultures of dissociated
cells, slice cultures offer the unique possibility to study the BBB
under different experimental conditions, meanwhile taking into
account the complex environment of the brain. Compared with
the existing BBB models, COSCs have the advantage that blood
vessels, albeit dissected into smaller fragments, remain in situ in a
maintained structure that allows cell–cell interactions between
natural in vivo partners.
Although vessels might perish because of the absence of in-
traluminal blood flow, two early ultrastructural studies in human
and newborn rat brain tissue (Wolff et al., 1974; Hauw et al.,
1975) indicated the survival of vessels in explanted brain tissue.
Additionally, more recent immunohistochemical approaches
demonstrated the viability of vessels (i.e., in presence of vascular
endothelial growth factor in rat cortical cultures) (Kremer et al.,
1997; Rosenstein et al., 1998; Moser et al., 2003).
Here, we have taken advantage of FGF-2 as a key molecule in
modulating the BBB, promoting angiogenesis and regulating en-
dothelial cell survival (Garberg, 1998; Sobue et al., 1999). Several
studies have implicated astrocytes or astrocytic factors in the de-
velopment and maintenance of BBB properties in endothelial
cells of the brain (Bauer and Bauer, 2000; Garberg, 1998). Among
the known astrocyte-derived growth factors, only FGF-2 mimics
the signaling actions of astrocytes to the BBB (Klint et al.,1999;
Sobue et al., 1999). FGF-2 is a prominent candidate to preserve
BBB integrity (Langford et al., 2005), it has been shown to tighten
in vitro BBBmodels (Sobue et al., 1999), and it may be one of the
supposed barrier-tightening factors secreted by rat C6 glioma
cells (Brown et al., 2003).
Here, we demonstrate for the first time in COSCs ofmice that,
in presence of 0.5–5 ng/ml FGF-2, vascular structures persist for
up to 10 dwhilemaintaining the structural integrity of the BBB. A
correlation between FGF-2 levels and the degree of tumor vascu-
larity was reported in vivo in the CSF of patients with astrocytic
brain tumors (Peles et al., 2004). The observed FGF-2 levels, how-
ever, were somewhat higher (20–50 ng/ml) in the clinical study.
Despite the initially lower number of vascular segments in
DIV 7 cultures compared with DIV 3 cultures, the increase in the
number of vessels after 0.5 and 5 ng/ml FGF-2was similar in both
groups (e.g., the number of vascular structures was 1.5 higher
after 0.5 ng/ml and doubled after 5 ng/ml FGF-2 independent of
the in vitro duration).Whether this is attributable to angiogenesis
or an improved survival of already existing blood vessels is not yet
clear. The fact that 50% of the vessels detectable after DIV 3
were lacking after DIV 7 makes the generation of new vessels
rather unlikely. Excessive amounts of 50 ng/ml FGF-2 were also
Figure 5. Astrocytes in untreated and FGF-2-treated slices. A–D, Untreated controls. E–K,
FGF-2-treated slices (5 ng/ml, DIV 7). A, E, FVIII-rAg labeling of vascular structures (red). B, F,
GFAP labeling of astrocytes (green). Insets in C andG are shown inD andH–K.A, In the absence
of FGF-2, the disintegration of cerebral vessels is apparent (note arrows showing dilated ves-
sels). E, In the presence of FGF-2, vascular structures appear intact. B, F, GFAP staining shows
star-shaped astrocytes, which try to maintain their endfeet around the dilated vascular struc-
tures (C, inset,D).G, Insets,H–K, In the FGF-2-treated slices, the astrocytic endfeet are in close
contact with vessels of different size and shape and surround the blood vessels in a regular
manner. Scale bars: A–C, F, G, 100m; D, H–K, 25m.
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ineffective in preventing loss of vessels compared with controls.
Thus, FGF-2 in moderate concentrations seems to prolong sur-
vival of blood vessels rather then promote angiogenesis.
In the presence of FGF-2, astrocytic endfeet surrounded each
individual blood vessel in a regular manner (Simard et al., 2003).
In the absence of FGF-2, the disintegration of cerebral vascular
structures is obvious. A dilation of vascular fragments occurred at
DIV 3 and most vessels were completely disintegrated at DIV 7.
However, even in the absence of FGF-2,
astrocytic endfeet tried to maintain con-
tact to the dilated vessels and no differ-
ences were found in the microanatomy of
astrocytes with or without FGF-2.
Thus, we conclude that, primarily, the
vessels themselves and not the astrocytes
were affected by the absence of FGF-2.
This was confirmed by an analysis of the
immunohistochemical localization of
FGFR1 inCOSCs by confocalmicroscopy.
FGFR1 was expressed mainly on blood
vessels. A significant amount of the recep-
tor colocalized with laminin, a constituent
of the endothelial basal lamina, whereas
there was no colocalization with astro-
cytes. The colocalization of FGFR1 and
laminin is in agreement with previous ev-
idence from cell culture experiments that
signaling via FGFR1 is dependent on the
composition of the extracellular matrix in
capillary endothelial cell differentiation,
and that laminin plays a pivotal role in
these cell-matrix interactions (Kanda et
al., 1999).
Survival and functioning of neurons in
organotypic slice cultures under control
culture conditions in the absence of FGF-2
have been demonstrated by Stoppini et al.
(1991), Yamamoto et al. (1992), andmany
others. We also found a good survival of
neurons in the untreated control COSCs
for the proposed time-frame (data not
shown), as well as in the FGF-2-treated
slices.
To exclude that the preservation of
blood vessels after FGF-2 treatment might
be related to an improved survival of the
neuronal and glial elements in the slice
cultures, we studied apoptotic cell death
with the apoptosis-marker caspase-3.
Whereas, in general, caspase-3 immuno-
reactivity was absent or very low in the
slice cultures, after 10 d in vitro, some
slices showed beginning tissue degenera-
tion in their center. No difference in
capase-3 immunoreactivity was found be-
tween control cultures and FGF-2-treated
cultures. Furthermore, cell death was re-
lated more to the nervous tissue of the
subcortical regions and to a much lesser
degree to the cortical regions of the slices.
Together, these results demonstrate that,
in the presence of FGF-2, cerebral blood
vessels are well preserved and that this
seems not to be caused by an indirect or artificial effect of astro-
cytes or neurons on the vascular network. However, future stud-
ies will clarify the signaling pathways downstream of FGF-
receptors and the mechanisms of vascular degeneration in the
absence of FGF-2.
It is long established that TJs constitute the anatomical basis of
the selective permeability of the BBB (for review, see Wolburg
and Lippoldt, 2002). Several peripheral membrane proteins such
Figure 6. Tight junctions of the BBB appear as intact structures. A, In the absence of FGF-2, the loss of tight junction proteins
(here exemplarily, claudin-5 labeling) indicates the loss of the integrity of the BBB. B–M, Immunostaining revealed a complex
network of tight junctions in the slices treatedwithmoderate FGF-2 concentrations (here, 0.5 ng/ml) indicating themaintenance
of the BBB. Note continuous large bands of claudin-5 (B–D), claudin-3 (G–K ), ZO-1 (L), and occludin (M ) delineating vascular
walls, intersections between different vessels (G,H, arrows) and adjacent endothelial cells (J,K, arrowheads). E, Laminin labeling
of vessels. F, Overlay of laminin and claudin-5. Scale bars, 100m.
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as ZO-1 were reported to concentrate at the cytoplasmic surface
of TJs (Schneeberger and Lynch, 1992; Anderson and van Itallie,
1995; Balda and Matter, 1998; Tsukita et al., 1999, 2001) and
integral membrane proteins are known to be localized at TJs (i.e.,
occludin and claudin) (Furuse et al., 1993, 1998).
Claudins are a major constituent of TJ strands (Tsukita et al.,
2001), which are copolymers of heterogeneous claudin species
(Furuse et al., 1999). Claudin-5 was found specifically in endo-
thelial cells, in large amounts especially in the brain (Morita et al.,
1999), leading to the idea that it is directly involved in the estab-
lishment of the BBB. Recently, the expression of claudin-3 on in
vivo healthy mouse CNS vessels was demonstrated (Wolburg et
al., 2003).
Tight junctions seem to play an important role in pathological
conditions of the CNS, because alterations in tight junction pro-
teins of the claudin family have been correlated with BBB perme-
ability changes in claudin-5-deficientmice (Nitta et al., 2003) and
in leaky blood vessels of dystrophic mdx mice (Nico et al., 2003)
as well as during ischemic stroke (Mark and Davis, 2002). The
selective loss of claudin-3 immunostaining in tumors or during
inflammation suggests that claudin-3 is a central component de-
termining the integrity of BBB TJs (Wolburg et al., 2003).
However, although occludin, claudin-5, and claudin-3 were
believed to restrict BBB permeability (Wolburg and Lippoldt,
2002), their expression must not always be correlated with the
tightness of the BBB. Removal of astrocytes from cocultures, for
example, did not cause any visible loss of tight junction mole-
cules, despite an early BBB opening to paracellular tracers
(Hamm et al., 2004). Furthermore, in some neuropathological
conditions, the selective loss of claudin-3, but not of claudin-5,
ZO-1, or occludin, from altered cerebral vessels indicated that the
loss of tight junction proteins might be a rather late event in BBB
breakdown (Wolburg et al., 2003). Yet, this seems to be in con-
trast to in vivo observations where a complete loss of tight junc-
tion proteins was observed in long-established pathological con-
ditions accompanied by BBB breakdown.
An important part of this study was to verify the presence of
claudin-3 and claudin-5 in the proposed in vitro model of FGF-
2-treated COSCs, which suggests well differentiated TJs and the
absence of major regressive changes concerning the structural
integrity of the BBB. Thus, we propose the COSC-FGF-2 model
as a suitable tool for mechanistic studies, especially of late or
more pronounced effects on the BBB (i.e., in inflammatory pro-
cesses during ischemia or neurodegenerative diseases when the
adjacent nervous tissue is strongly involved in the pathological
event and information on specific cellular interactions and sig-
nals leading to BBB breakdown is required). However, the model
will also allow study of early and more subtle changes at the BBB
distinct from the complete loss of tight junction proteins (e.g.,
their phosphorylation). Importantly, because of the relative sim-
plicity of the system, COSCs can be readily manipulated and
subjected to different insults such as hypoxia, glucose depriva-
tion, and pharmacological treatments to assist in understanding
BBB disturbances.
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